Filing Details

Accession Number:
0001235802-23-000073
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-26 16:42:45
Reporting Period:
2023-06-23
Accepted Time:
2023-06-26 16:42:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401040 Diamedica Therapeutics Inc. DMAC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1759822 Michael Randall Giuffre 301 Carlson Parkway, Suite 210
Minneapolis MN 55305
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Shares, No Par Value Per Share Acquisiton 2023-06-23 65,000 $3.91 360,355 No 4 P Direct
Voting Common Shares, No Par Value Per Share Disposition 2023-06-23 15,000 $0.00 345,355 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 G Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Voting Common Shares, No Par Value Per Share 25,573 Indirect See footnote
Voting Common Shares, No Par Value Per Share 21,070 Indirect By Spouse
Footnotes
  1. Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually.
  2. These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.